Clinical Trial Update: Acotral® Versus Zetia® Ezetimibe Bioequivalance Study. [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study comparing Acotral with Zetia (ezetimibe) in hypercholesterolemia, with the trial status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Acotral
• Zetia (ezetimibe)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypercholesterolaemia | Phase 1 | Status: COMPLETED